IBC Life Sciences

There are other Asia Pharma R&D events out there...

However, IBC's 5th Annual China Pharmaceutical R&D Summit is THE Premier Pharma R&D Event for Top-Level Executives.

We know it is important to you that you attend the conference that will provide you with the most return. And with multiple pharma events out there, how do you know which one to choose?

China 2010 Pharmaceutical R&D Summit, is the premier China R&D event exploring business-critical issues relating to the pharmaceutical development in China.

Here's a glance at what our 2010 event offers our attendees that no other Pharma event in Asia will cover:

• Hear from the Insiders - VPs and Heads of R&Ds of Roche, Pfizer, Eli Lilly, Sanofi-Aventis as well as top domestic pharmas will present their insiders' views on their experiences, perspectives and future visions.
• Distinguished Keynotes from Sanofi-Aventis, Pfizer, Merck and Jiangsu Hengrui will present their insightful views on their vision of China as part of their global strategies.
• Renowned professors from leading universities of Tsinghua, Peking, Fudan, SIMM etc. will give updates on their new drug candidates discovery, functions of structural biology in innovative drug discovery, novel compound discovery from natural resources and drug delivery systems etc.
• A panel of distinguished experts will explore the regulations, ethics, medical governance, benefits and risks, and safety management of FIH trials in China, and attempt to answer the question - is China ready for FIH trials?
• In-depth sessions and discussions on Impact of China's Healthcare Reform; Organizational Development & Talent Management in China; China vis-à-vis other Emerging Markets; From Biosimiilars/Biobetters to Novel Biologics.

Only at IBC's premier China Pharmaceutical R&D Summit can you find the latest and hottest issues confronting the leadership of China today, and how they are addressing them.

» View the full conference agenda